期刊文献+

PTTG、c-myc基因在骨髓增生异常综合征中表达的研究 被引量:1

The study of the expression on pitnitary tumor- transforming gene and c-myc gene in patients with myelodysplastic syndrome
下载PDF
导出
摘要 目的 研究垂体瘤转化基因 (PTTG)和 c- myc基因在骨髓增生异常综合征 (MDS)患者中的表达并分析其与 MDS的关系。方法 采用 RT- PCR方法检测 32例 MDS患者及 10例正常骨髓中 PTTG和 c- myc基因m RNA表达。结果  MDS患者 PTTG和 c- m yc基因表达明显高于对照组 (P<0 .0 5 ) ;PTTG和 c- myc基因在RAEB- 1及 RAEB- 2组中的表达高于 RA及 RAS(P<0 .0 5 ) ,RAEB- 1及 RAEB- 2组中的表达差异无显著意义(P>0 .0 5 )。结论  PTTG和 c- m yc基因的过表达可能与 MDS的发生发展有关。 Objective To explore the expression of PTTG and c-myc gene in myelodysplastic syndrome (MDS) and their relationship with MDS.Methods Expression of PTTG and c-myc gene mRNA was detected in BMMNC from 32 patients with MDS and 10 normal controls by reverse transcriptase-polymerase chain reation (RT-PCR) .Results Expression of PTTG and c-myc gene in BMMNC was significantly higher in MDS patients than in normal controls(P<0.05).Acording to FAB classification the expression of PTTG and c-myc gene in BMMNC was higher in type RAEB-1 and RAEB-2 than RA and RAS(P<0.05).The expression of PTTG and c-myc gene in type RAEB-1 and RAEB-2 showed no significance (P>0.05).Conclusion Overexpression of oncogene PTTG and c-myc may be related to the progression and genesis of MDS.
出处 《山东医药》 CAS 北大核心 2004年第31期8-9,共2页 Shandong Medical Journal
关键词 PTTG C-MYC基因 MDS 过表达 骨髓增生异常综合征 患者 对照组 结论 目的 转化 Myelodysplastic syndrome Pituitary tumor-transforming gene Reverse transcriptase-polymerase chain reaction
  • 相关文献

参考文献2

  • 1Dominguez A,Ramos-Morales F,Romero F,et al.A human homologue of rat PTTG is overexpressed in hematopoietic neoplasms,evidence for a transcriptional activation function of hPTTG.Oncogene,1998,17:2187~2193.
  • 2Pei L.Identification of c-myc as a down-stream target for pituitary tumor-transforming gene.J Biol Chem,2001,276(11):8484~8491.

同被引文献8

  • 1张树平,王桂花,王垣芳,姜文国,栾海云.大鼠局灶脑缺血基质金属蛋白酶-2的表达[J].滨州医学院学报,2007,30(4):247-248. 被引量:6
  • 2张之南,沈悌.血液病诊断及疗效标准[M].第2版.北京:科学出版社,1999:171-173.
  • 3Felsher DW, Bishop JM, Reversible tumorigenesis by MYC in hematopoietic lineages[J]. Mol Cell, 1999,4(2) :199-207.
  • 4Borregaard N, Cowland B .Granules of the human neutrophilic poly- morphonuclear leukocyte[J]. Blood,1997,89(10) :3503-3521.
  • 5Janowska-wieczorek A, Marquez LA, Matsuzaki A, et al. Expression of matrix metalloproteinase( MMP-2 and MMP-9 ) and tissue inhibitors of metalloproteinases( TIMP-1 and TIMP-2 ) in acute myelogenous leukaemia blast: comparision with normal bone marrow cells [J]. Br J Haematol, 1999,105(2) :402-411,
  • 6Omoto E, Deguchi S, Takaba S, et al. Low-dose melphalan for treatment of high-risk myelodysplastic syndromes [ J ]. Leukemia, 1996,10 (4) :609-614.
  • 7Robak T, Szmigielska-Kap,Urbafiska RH. Efficacy and toxicity of low-dose melphalan in myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia [ J ], Neoplasma, 2003,50 (3) : 172-175.
  • 8徐泽锋,邹煦,肖志坚.单用小剂量马法兰成功治疗老年低增生性RAEB-Ⅱ型一例[J].中华血液学杂志,2003,24(3):148-148. 被引量:3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部